Jazz Pharmaceuticals, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2003, the company has established itself as a leader in developing innovative treatments for neurological and sleep disorders, as well as oncology. With a strong focus on rare diseases, Jazz Pharmaceuticals has made significant strides in addressing unmet medical needs. The company’s core products, including Xyrem and Sunosi, are distinguished by their unique formulations and targeted therapeutic approaches. Over the years, Jazz has achieved notable milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Today, Jazz Pharmaceuticals is recognised for its commitment to improving patient outcomes and maintaining a robust position in the competitive biopharmaceutical landscape.
We don't have data for Jazz Pharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company